ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 663790 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 663790; 2) Community: the network communities that were significantly associated with the response to NSC 663790; 3) Molecule: the relationships between components within communities and NSC 663790; 4) MDR: the compounds that were significantly associated with the NSC 663790.

NSC Compound Enrichment Correlation
NSC 641245 Benzenebutanamide, N-(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)-.alpha.,.gamma.-dioxo-2-(3,4-dihydro- 3,4-dioxo-2-naphthalenyl)- 0.0352786308082228 0.19923153
NSC 644651 Null 0.0352786308082228 0.0085295449
NSC 109834 Null 0.0415729612483928 0.2664381
NSC 119875 Cisplatin 0.0415729612483928 0.56673559
NSC 15309 2,5-Cyclohexadiene-1,4-dione, 2,5-dimethyl- (9CI) 0.0415729612483928 0.014421991
NSC 179187 Salasdine 0.0415729612483928 0.16500059
NSC 249992 M-AMSA 0.0415729612483928 0.6021722
NSC 279836 Mitoxantrone 0.0415729612483928 0.58605563
NSC 281617 Ethanol, 2,2'[[3-methyl-4-[[[4-[5-methyl-2-(phenylmethyl)-4-thiazolyl]phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester) 0.0415729612483928 0.4063819
NSC 295500 Camptothecin Derivative 0.0415729612483928 0.5399978
Total:63  Current:47    [First] [Prev] [Next] [Last]